US 9161948
Peptide oligonucleotide conjugates
granted A61KA61K31/712A61K31/713
Quick answer
US patent 9161948 (Peptide oligonucleotide conjugates) held by Sarepta Therapeutics, Inc. expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 81
- CPC classes
- A61K, A61K31/712, A61K31/713, A61K47/64, A61K47/645